162 related articles for article (PubMed ID: 24993398)
1. Accelerated telomere reduction and hepatocyte senescence in tolerated human liver allografts.
Aini W; Miyagawa-Hayashino A; Ozeki M; Adeeb S; Hirata M; Tamaki K; Uemoto S; Haga H
Transpl Immunol; 2014 Aug; 31(2):55-9. PubMed ID: 24993398
[TBL] [Abstract][Full Text] [Related]
2. Telomere shortening and karyotypic alterations in hepatocytes in long-term transplanted human liver allografts.
Aini W; Miyagawa-Hayashino A; Tsuruyama T; Hashimoto S; Sumiyoshi S; Ozeki M; Tamaki K; Uemoto S; Haga H
Transpl Int; 2012 Sep; 25(9):956-66. PubMed ID: 22775391
[TBL] [Abstract][Full Text] [Related]
3. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
[TBL] [Abstract][Full Text] [Related]
5. Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: Comparison with telomere-specific quantitative FISH and p21 immunohistochemistry.
Nakajima T; Nakashima T; Okada Y; Jo M; Nishikawa T; Mitsumoto Y; Katagishi T; Kimura H; Itoh Y; Kagawa K; Yoshikawa T
Pathol Int; 2010 Mar; 60(3):175-83. PubMed ID: 20403043
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence in pretransplant renal biopsies predicts postoperative organ function.
McGlynn LM; Stevenson K; Lamb K; Zino S; Brown M; Prina A; Kingsmore D; Shiels PG
Aging Cell; 2009 Feb; 8(1):45-51. PubMed ID: 19067655
[TBL] [Abstract][Full Text] [Related]
7. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
8. One hundred in situ split-liver transplantations: a single-center experience.
Yersiz H; Renz JF; Farmer DG; Hisatake GM; McDiarmid SV; Busuttil RW
Ann Surg; 2003 Oct; 238(4):496-505; discussion 506-7. PubMed ID: 14530721
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
[TBL] [Abstract][Full Text] [Related]
10. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
[TBL] [Abstract][Full Text] [Related]
11. New evidence for a role of allograft accommodation in long-term tolerance.
Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
[TBL] [Abstract][Full Text] [Related]
12. Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation.
Nagasaki K; Obara H; Xiong A; Kambham N; Strober S; Esquivel CO; Millan MT
Transplantation; 2007 Sep; 84(5):619-28. PubMed ID: 17876275
[TBL] [Abstract][Full Text] [Related]
13. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
14. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
[TBL] [Abstract][Full Text] [Related]
15. Telomere shortening in liver transplant recipients is not influenced by underlying disease or metabolic derangements.
Uziel O; Laish I; Bulcheniko M; Harif Y; Kochavi-Shalem N; Aharoni M; Braunstein R; Lahav M; Ben-Ari Z
Ann Transplant; 2013 Oct; 18():567-75. PubMed ID: 24141383
[TBL] [Abstract][Full Text] [Related]
16. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.
Smith CM; Davies DB; McBride MA
Clin Transpl; 2000; ():19-30. PubMed ID: 11512312
[TBL] [Abstract][Full Text] [Related]
18. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
19. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation.
Koppelstaetter C; Schratzberger G; Perco P; Hofer J; Mark W; Ollinger R; Oberbauer R; Schwarz C; Mitterbauer C; Kainz A; Karkoszka H; Wiecek A; Mayer B; Mayer G
Aging Cell; 2008 Aug; 7(4):491-7. PubMed ID: 18462273
[TBL] [Abstract][Full Text] [Related]
20. Graft fibrosis after pediatric liver transplantation: ten years of follow-up.
Scheenstra R; Peeters PM; Verkade HJ; Gouw AS
Hepatology; 2009 Mar; 49(3):880-6. PubMed ID: 19101912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
